Skip to content Skip to sidebar Skip to footer
Home / Risks of Having a Baby Over 4000 Grams

Risks of Having a Baby Over 4000 Grams

Post a Comment

Medical condition

Large for gestational historic period
Other names Macrosomia
New-baby-boy-weight-11-pounds.jpg
LGA: A healthy 11-pound (5.0 kg) newborn child, delivered vaginally without complications (41 weeks; fourth kid; no gestational diabetes)
Specialty Obstetrics, pediatrics

Large for gestational age (LGA) is a term used to describe infants that are built-in with an abnormally high weight, specifically in the 90th percentile or to a higher place, compared to other babies of the aforementioned developmental age.[1] [2] [three] Macrosomia is a similar term that describes excessive birth weight, but refers to an accented measurement, regardless of gestational historic period.[4] Typically the threshold for diagnosing macrosomia is a body weight of between four,000 and 4,500 grams (8 lb 13 oz and 9 lb 15 oz), or more, measured at birth, only at that place are difficulties reaching a universal understanding of this definition.[iv]

Evaluating an infant for macrosomia or LGA tin can aid identify risks associated with their nascency, including labor complications of both the parent and the kid, potential long-term health complications of the child, and infant bloodshed.[5]

Signs and symptoms [edit]

Fetal macrosomia and LGA oftentimes do not present with noticeable patient symptoms. Important signs include large fundal height (uterus size) and excessive amniotic fluid (polyhydramnios).[6] Fundal top can be measured from the superlative of the uterus to the pubic os and indicates that the newborn is likely large in volume. Excessive amniotic fluid indicates that the fetus' urine output is larger than expected, indicating a larger baby than normal; some symptoms of excessive amniotic fluid include

  • shortness of breath
  • swelling of lower extremities & intestinal wall
  • uterine discomfort or contractions
  • fetal malposition, such equally breech presentation.[7]

Complications [edit]

LGA or macrosomic births can pb to complications for both the female parent and the infant.[8]

Infant complications [edit]

Mutual risks in LGA babies include shoulder dystocia,[5] hypoglycemia,[5] brachial plexus injuries,[9] metatarsus adductus, hip subluxation[ten] and talipes calcaneovalgus, due to intrauterine deformation.[10]

Shoulder dystocia occurs when the babe's shoulder becomes impacted on the mother's pubic symphysis during birth.[11] Newborns with shoulder dystocia are at hazard of temporary or permanent nerve harm to the babe'due south arm, or other injuries such as fracture.[12] Both increased nascence weight and diabetes in the gestational parent are contained risk factors seen to increase risk of shoulder dystocia.[12] In non-diabetic women, shoulder dystocia happens 0.65% of the time in babies that weigh less than 8 pounds 13 ounces (4,000 g), 6.vii% of the time in babies that weigh viii pounds 13 ounces (4,000 one thousand) to 9 pounds fifteen ounces (4,500 g), and 14.5% of the time in babies that counterbalance more than 9 pounds xv ounces (4,500 g).[13] In diabetic women, shoulder dystocia happens 2.2% of the time in babies that weigh less than 8 pounds 13 ounces (iv,000 g), 13.nine% of the fourth dimension in babies that weigh eight pounds thirteen ounces (four,000 1000) to ix pounds 15 ounces (four,500 one thousand), and 52.5% of the time in babies that weigh more than 9 pounds 15 ounces (4,500 g).[13] Although larger babies are at higher chance for shoulder dystocia, about cases of shoulder dystocia happen in smaller babies considering at that place are many more pocket-sized and normal-size babies existence built-in than large babies.[14]

LGA babies are at higher risk of hypoglycemia in the neonatal menses, independent of whether the mother has diabetes.[15] Hypoglycemia, as well as hyperbilirubinemia and polycythemia, occur as a result of hyperinsulinemia in the fetus.[16]

Loftier nascence weight may also impact the baby in the long term as studies have shown associations with increased risk of overweight, obesity, and type ii diabetes mellitus.[4] [17] [eighteen] Studies accept shown that the long-term overweight risk is doubled when the nativity weight is greater than 4,000 chiliad. The chance of type 2 diabetes mellitus equally an developed is 19% higher babies weighing more than 4,500 g at birth compared to those with nascency weights between four,000 g and four,500 1000. [19]

Meaning mother complications [edit]

Complications of the pregnant mother include: emergency cesarean section, postpartum hemorrhage, and obstetric anal sphincter injury.[8] Compared to pregnancies without macrosomia, pregnant women giving nascency to newborns weighing between iv,000 grams and 4,500 grams are at two times greater risk of complications, and those giving birth to infants over iv,500 grams are at iii times greater risk.[8]

Schematic representation of macrosomia/LGA risk factors and related complications.

Causes [edit]

Multiple factors have been shown to increase likelihood of baby macrosomia including: preexisting obesity, diabetes, or dyslipidemia of the female parent, gestational diabetes, postal service-term pregnancy, prior history of a macrosomic nativity, genetics, and other factors.[iv]

Risk factors [edit]

Diabetes of the mother [edit]

One of the principal risk factors of LGA births and macrosomia is poorly-controlled maternal diabetes, especially gestational diabetes (GD), equally well every bit preexisting blazon 2 diabetes mellitus (DM).[20] The risk of having a macrosomic fetus is three times greater in mothers with diabetes than those without diabetes.[21]

Obesity in the mother [edit]

Obesity prior to pregnancy and maternal weight proceeds above recommended guidelines during pregnancy are another key hazard cistron for macrosomia or LGA infants.[22] [23] [24]  It has been demonstrated that while maternal obesity and gestational diabetes are independent risk factors for LGA and macrosomia, they can act synergistically, with even higher take a chance of macrosomia when both are present.[four] [21]

Genetics [edit]

Genetics tin can likewise play a part in having an LGA baby and it is seen that taller, heavier parents tend to accept larger babies.[25] Genetic disorders of overgrowth (e.g. Beckwith–Wiedemann syndrome, Sotos syndrome, Perlman syndrome, Simpson-Golabi-Behmel syndrome) are often characterized by macrosomia.[26] [27]

Other gamble factors [edit]

  • Gestational age: pregnancies that become across 40 weeks increase incidence of an LGA infant[21]
  • Fetal sexual activity: male infants tend to weigh more than female infants[9]
  • Multiparity: giving birth to previous LGA infants vs. non-LGA infants[9]
  • Frozen embryo transfer equally fertility treatment, equally compared with fresh embryo transfer or no artificial assistance[28] [29]

Mechanism [edit]

How each of these factors leads to excess fetal growth is circuitous and not completed understood.[4] [30]

Traditionally, the Pedersen hypothesis has been used to explain the mechanism in which uncontrolled gestational diabetes can lead to macrosomia, and many aspects of information technology take been confirmed with further studies.[21] This caption proposes that impaired glucose control in the mother leads to a hyperglycemic state for the fetus, which leads to a hyperinsulinemia response, in turn causing increased glucose metabolism, fat degradation, and excess growth.[21] [30] [31]

It has also been shown that different patterns of excess fetal growth are seen in diabetic associated macrosomia compared to other predisposing factors, suggesting unlike underlying mechanisms.[4] [30] Specifically, macrosomic infants associated with glucose abnormalities are seen to accept increased trunk fat, larger shoulders and intestinal circumference.[4] [30]

Diagnosis [edit]

Weight vs gestational Age.jpg

Diagnosing fetal macrosomia cannot be performed until subsequently birth, as evaluating a baby'due south weight in the womb may be inaccurate.[21] While ultrasound has been the primary method for diagnosing LGA, this form of fetal weight assessment remains imprecise, equally the fetus is a highly variable structure in regards to density and weight— no matter the gestational age.[21] Ultrasonography involves an algorithm that incorporates biometric measurements of the fetus, such every bit biparietal diameter (BPD), caput circumference (HC), abdominal circumference (AC), and femur length (FL), to summate the estimated fetal weight (EFW).[32] Variability of fetal weight estimations has been linked to differences due to sensitivity and specificity of ultrasound algorithms as well as to the individual performing the ultrasound examination.[33]

In addition to sonography, fetal weight can besides be assessed using clinical and maternal methods. Clinical methods for estimating fetal weight involves measuring the mother's symphysis-fundal height and performing Leopold'due south maneuvers, which can assist with determining the fetus position in utero in improver to size.[33] Yet, as this method relies heavily on practitioner feel and technique, it does non provide an authentic and definite diagnosis of an LGA infant and simply would only serve as a potential indication of suspected macrosomia.[33] Fetal weight can also be estimated through a mother's subjective assessment of the fetus size, only this method is dependent on a mother'south experience with past pregnancies and may not exist clinically useful.[33] There are new methods beingness studied for their accuracy in predicting fetal weight, such as measuring fetal soft tissue, but more than research needs to be done to find a consistent, reliable method.[34]

Prevention [edit]

LGA and fetal macrosomia associated with poor glycemic control can be prevented by effective blood glucose management below a hateful blood glucose level of 100 mg/dl before and during pregnancy; additionally, closely monitoring weight gain and diet during pregnancy tin aid to foreclose LGA and fetal macrosomia.[35] [36] Women with obesity that undergo weight loss tin can greatly decrease their chances of having a macrosomic or LGA infant.[37] Additionally, regular prenatal care and routine cheque-ups with one'south physician are of import in planning pregnancy, especially if one has obesity, diabetes, hypertension, or other conditions before conception.[38]

Screening [edit]

Most screening for LGA and macrosomia occurs during prenatal cheque-ups, where both fundal superlative and ultrasound scans tin can requite an approximate measurement of the babe's proportions.[39] Ii-dimensional ultrasound tin can be used to screen for macrosomia and LGA but estimations are generally not precise at any gestational age until birth.[40]

Management [edit]

Consecration of labor at or near term for women with a baby of suspected macrosomia has been proposed as a treatment method, as information technology stops fetal growth and results in babies with a lower nascence weight, fewer bone fractures, and less incidence of shoulder dystocia.[11] However, this method could increase the number of women with perineal tears, and failed inductions tin prompt the demand for emergency cesarean sections.[xi] LGA babies are more two times likely to be delivered past Cesarean section, compared to infants under 4000 grams (below the threshold of macrosomia).[41] Predicting a baby's weight can be inaccurate and women could be worried unnecessarily, and asking their labor to be induced without a medical reason.[11] Doctors disagree whether women should be induced for suspected macrosomia and more research is needed to find out what is best for women and their babies.[11]

Elective cesarean department has also been presented every bit a potential delivery method for infants of suspected macrosomia, equally it can serve to forbid possible birth trauma. However, the American Higher of Obstetricians and Gynecologists recommends that cesarean delivery should only be considered if the fetus is an estimated weight of at to the lowest degree 5,000 grams in non-diabetic mothers and at to the lowest degree iv,500 grams in diabetic mothers.[42] A number needed to treat assay determined that approximately 3,700 women with suspected fetal macrosomia would have to undergo an unnecessary cesarean section in lodge to forestall ane incident of brachial plexus injuries secondary to shoulder dystocia.[ix]

Direction of gestational diabetes through dietary modifications and anti-diabetic medications has been shown to subtract the incidence of LGA.[43] The use of metformin to control maternal blood glucose levels has shown to exist more effective than using insulin alone in reducing the likelihood of fetal macrosomia.[44] In that location is a 20% lower chance of having an LGA baby when using metformin to manage diabetes compared to using insulin.[45]

Modifiable take chances factors that increase the incidence of LGA births, such as gestational weight gain higher up recommended BMI guidelines, tin can be managed with lifestyle modifications, including maintaining a balanced nutrition and exercising.[46] [47] Such interventions can help mothers achieve the recommended gestational weight and lower the incidence of fetal macrosomia in obese and overweight women.[46] [47] The Globe Wellness Organization as well recommends that mothers aim for their recommended BMI prior to conception.[24] In general, obese mothers or women with excessive gestational weight gain may have higher risk of pregnancy complications (ranging from LGA, shoulder dystocia, etc.).[48]

Epidemiology [edit]

In healthy pregnancies without pre-term or post-term health complications, big for gestational historic period, or fetal macrosomia accept been observed to touch on around 12% of newborns.[11] By comparison, women with gestational diabetes are at an increased risk of giving birth to LGA babies, where ~fifteen-45% of neonates may exist affected.[11] In 2017, the National Eye of Health Statistics found that 7.8% of live-born infants born in the United States run across the definition of macrosomia, where their birth weight surpasses the threshold of 4000 grams (above ~8.8 pounds).[11] Women in Europe and the United States tend to have college pre-term body weight and have increased gestational weight during pregnancy compared to women in east asia.[49] Thus, women in Europe and the The states, with higher gestational weight gain, tend to have higher associated gamble of LGA infants, macrosomia and cesarean.[49] In European countries, the prevalence of births of newborns weighing between four,000 m and iv,499 m is 8% to 21%, and in Asian countries the prevalence is between 1% and 8%.[fifty] In full general, rates of LGA infants accept increased 15-25% in many countries including the United States, Canada, Frg, Denmark, Scotland and more in the past 20–xxx years, suggesting an increase in LGA births worldwide.[51]

References [edit]

  1. ^ Szmyd B, Biedrzycka M, Karuga FF, Strzelecka I, Respondek-Liberska M (2021). "Interventricular Septal Thickness as a Diagnostic Mark of Fetal Macrosomia". Journal of Clinical Medicine. 10 (949): 949. doi:10.3390/jcm10050949. PMC7957748. PMID 33804406.
  2. ^ Henriksen T (2008). "The macrosomic fetus: a challenge in current obstetrics". Acta Obstetricia et Gynecologica Scandinavica. 87 (2): 134–45. doi:10.1080/00016340801899289. PMID 18231880. S2CID 38118355.
  3. ^ McGrath RT, Glastras SJ, Hocking SL, Fulcher GR (Baronial 2018). "Large-for-Gestational-Age Neonates in Blazon 1 Diabetes and Pregnancy: Contribution of Factors Beyond Hyperglycemia". Diabetes Care. 41 (8): 1821–1828. doi:10.2337/dc18-0551. PMID 30030258. S2CID 207369659.
  4. ^ a b c d e f m h Barth Jr WH, Jackson R, et al. (Commission on Practice Bulletins—Obstetrics) (January 2020). "Macrosomia: ACOG Exercise Bulletin, Number 216". Obstetrics and Gynecology. 135 (1): e18–e35. doi:10.1097/AOG.0000000000003606. PMID 31856124.
  5. ^ a b c Boulet SL, Alexander GR, Salihu HM, Laissez passer Chiliad (May 2003). "Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk". American Journal of Obstetrics and Gynecology. 188 (5): 1372–8. doi:10.1067/mob.2003.302. PMID 12748514.
  6. ^ "Fetal macrosomia - Symptoms and causes". Mayo Dispensary . Retrieved 2021-09-15 .
  7. ^ "Fetal macrosomia - Symptoms and causes". Mayo Dispensary . Retrieved 2021-09-fifteen .
  8. ^ a b c Beta J, Khan N, Khalil A, Fiolna M, Ramadan G, Akolekar R (September 2019). "Maternal and neonatal complications of fetal macrosomia: systematic review and meta-assay". Ultrasound in Obstetrics & Gynecology. 54 (3): 308–318. doi:x.1002/uog.20279. PMID 30938004.
  9. ^ a b c d Zamorski MA, Biggs WS (January 2001). "Management of suspected fetal macrosomia". American Family Doctor. 63 (2): 302–6. PMID 11201695.
  10. ^ a b Lapunzina P, Camelo JS, Rittler Thou, Castilla EE (Feb 2002). "Risks of congenital anomalies in big for gestational age infants". The Periodical of Pediatrics. 140 (ii): 200–4. doi:10.1067/mpd.2002.121696. PMID 11865271.
  11. ^ a b c d eastward f g h Boulvain Thou, Irion O, Dowswell T, Thornton JG, et al. (Cochrane Pregnancy and Childbirth Group) (May 2016). "Induction of labour at or near term for suspected fetal macrosomia". The Cochrane Database of Systematic Reviews (5): CD000938. doi:10.1002/14651858.CD000938.pub2. PMC7032677. PMID 27208913.
  12. ^ a b Immature BC, Ecker JL (February 2013). "Fetal macrosomia and shoulder dystocia in women with gestational diabetes: risks amenable to treatment?". Current Diabetes Reports. 13 (ane): 12–viii. doi:10.1007/s11892-012-0338-8. PMID 23076441. S2CID 4385185.
  13. ^ a b Rouse DJ, Owen J, Goldenberg RL, Cliver SP (Nov 1996). "The effectiveness and costs of constituent cesarean delivery for fetal macrosomia diagnosed by ultrasound". JAMA. 276 (18): 1480–half dozen. doi:10.1001/jama.1996.03540180036030. PMID 8903259.
  14. ^ Morrison JC, Sanders JR, Magann EF, Wiser WL (December 1992). "The diagnosis and management of dystocia of the shoulder". Surgery, Gynecology & Obstetrics. 175 (6): 515–22. PMID 1448731.
  15. ^ Rozance PJ (February 2014). "Update on neonatal hypoglycemia". Current Opinion in Endocrinology, Diabetes and Obesity. 21 (one): 45–l. doi:10.1097/MED.0000000000000027. PMC4012366. PMID 24275620.
  16. ^ Mayer C, Joseph KS (Feb 2013). "Fetal growth: a review of terms, concepts and issues relevant to obstetrics". Ultrasound in Obstetrics & Gynecology. 41 (2): 136–45. doi:ten.1002/uog.11204. PMID 22648955. S2CID 13304341.
  17. ^ Baird J, Fisher D, Lucas P, Kleijnen J, Roberts H, Law C (October 2005). "Being big or growing fast: systematic review of size and growth in infancy and later obesity". BMJ. 331 (7522): 929. doi:ten.1136/bmj.38586.411273.E0. PMC1261184. PMID 16227306.
  18. ^ Schellong K, Schulz S, Harder T, Plagemann A (2012). Hernandez AV (ed.). "Birth weight and long-term overweight risk: systematic review and a meta-analysis including 643,902 persons from 66 studies and 26 countries globally". PLOS One. 7 (10): e47776. Bibcode:2012PLoSO...747776S. doi:10.1371/journal.pone.0047776. PMC3474767. PMID 23082214.
  19. ^ Knop MR, Geng TT, Gorny AW, Ding R, Li C, Ley SH, Huang T (December 2018). "Birth Weight and Chance of Type 2 Diabetes Mellitus, Cardiovascular Disease, and Hypertension in Adults: A Meta-Analysis of 7 646 267 Participants From 135 Studies". Journal of the American Middle Clan. 7 (23): e008870. doi:10.1161/JAHA.118.008870. PMC6405546. PMID 30486715.
  20. ^ Leipold H, Worda C, Gruber CJ, Kautzky-Willer A, Husslein PW, Bancher-Todesca D (August 2005). "Large-for-gestational-age newborns in women with insulin-treated gestational diabetes under strict metabolic control". Wiener Klinische Wochenschrift. 117 (15–16): 521–v. doi:x.1007/s00508-005-0404-1. PMID 16160802. S2CID 7465313.
  21. ^ a b c d due east f g Kc Chiliad, Shakya S, Zhang H (2015). "Gestational diabetes mellitus and macrosomia: a literature review". Annals of Nutrition & Metabolism. 66 Suppl 2 (Suppl. 2): 14–20. doi:10.1159/000371628. PMID 26045324. S2CID 6536421.
  22. ^ Boubred F, Pauly V, Romain F, Fond G, Boyer L (2020-06-05). Farrar D (ed.). "The role of neighbourhood socioeconomic status in large for gestational age". PLOS ONE. 15 (six): e0233416. Bibcode:2020PLoSO..1533416B. doi:10.1371/journal.pone.0233416. PMC7274403. PMID 32502147.
  23. ^ Henriksen T (Feb 2008). "The macrosomic fetus: a claiming in current obstetrics". Acta Obstetricia et Gynecologica Scandinavica. 87 (2): 134–45. doi:ten.1080/00016340801899289. PMID 18231880. S2CID 38118355.
  24. ^ a b Goldstein RF, Abell SK, Ranasinha S, Misso K, Boyle JA, Black MH, et al. (June 2017). "Clan of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis". JAMA. 317 (21): 2207–2225. doi:10.1001/jama.2017.3635. PMC5815056. PMID 28586887.
  25. ^ Christian M, Gustafsson J (2017). Pediatrik (2 uppl ed.). ISBN9789147112968. OCLC 1001668564.
  26. ^ "Beckwith-Wiedemann syndrome". Genetics Domicile Reference . Retrieved 2020-07-xxx .
  27. ^ Vora N, Bianchi DW (October 2009). "Genetic considerations in the prenatal diagnosis of overgrowth syndromes". Prenatal Diagnosis. 29 (10): 923–9. doi:10.1002/pd.2319. PMC4426974. PMID 19609940.
  28. ^ Berntsen S, Pinborg A (May 2018). "Large for gestational age and macrosomia in singletons built-in after frozen/thawed embryo transfer (FET) in assisted reproductive technology (Art)". Birth Defects Research. 110 (8): 630–643. doi:10.1002/bdr2.1219. PMID 29714057. S2CID 25437950.
  29. ^ Orvieto R, Kirshenbaum M, Gleicher N (2020). "Is Embryo Cryopreservation Causing Macrosomia-and What Else?". Frontiers in Endocrinology. xi: nineteen. doi:10.3389/fendo.2020.00019. PMC6997460. PMID 32047479.
  30. ^ a b c d Avery's diseases of the newborn. Christine A. Gleason, Sherin U. Devaskar, Mary Ellen Avery (ninth ed.). Philadelphia, PA: Elsevier/Saunders. 2012. ISBN1-4557-2714-8. OCLC 768412368. {{cite volume}}: CS1 maint: others (link)
  31. ^ Olmos, Pablo; Martelo, Grettel; Reimer, Verena; Rigotti, Attilio; Busso, Dolores; Belmar, Cristián; González, Rogelio; Goldenberg, Denisse; Samith, Bárbara; Santos, José-Luis; Escalona, Manuel (November 2013). "[Nutrients other than glucose might explain fetal overgrowth in gestational diabetic pregnancies]". Revista Medica De Republic of chile. 141 (11): 1441–1448. doi:x.4067/S0034-98872013001100011. ISSN 0717-6163. PMID 24718471.
  32. ^ Coomarasamy A, Connock G, Thornton J, Khan KS (November 2005). "Accurateness of ultrasound biometry in the prediction of macrosomia: a systematic quantitative review". BJOG. 112 (11): 1461–6. doi:10.1111/j.1471-0528.2005.00702.x. PMID 16225563. S2CID 34330598.
  33. ^ a b c d Ray EM, Alhusen JL (2016). "The Suspected Macrosomic Fetus at Term: A Clinical Dilemma". Periodical of Midwifery & Women's Wellness. 61 (2): 263–9. doi:ten.1111/jmwh.12414. PMID 26869131.
  34. ^ Warska A, Maliszewska A, Wnuk A, Szyszka B, Sawicki Due west, Cendrowski K (March 2018). "Electric current knowledge on the use of ultrasound measurements of fetal soft tissues for the cess of pregnancy development". Journal of Ultrasonography. 18 (72): 50–55. doi:x.15557/JoU.2018.0008. PMC5911719. PMID 29844941.
  35. ^ "Large for Gestational Historic period Babies: Reasons, Signs & Treatment". parenting.firstcry.com . Retrieved 2021-09-15 .
  36. ^ "UpToDate". www.uptodate.com . Retrieved 2021-09-15 .
  37. ^ "UpToDate". www.uptodate.com . Retrieved 2021-09-15 .
  38. ^ "Large for Gestational Age Babies: Reasons, Signs & Handling". parenting.firstcry.com . Retrieved 2021-09-15 .
  39. ^ "Fetal Macrosomia". Obstetric Imaging: Fetal Diagnosis and Care: 460–462.e1. 2018-01-01. doi:ten.1016/B978-0-323-44548-1.00108-X.
  40. ^ "UpToDate". www.uptodate.com . Retrieved 2021-09-15 .
  41. ^ Steer P (Feb 2004). "The management of large and small for gestational age fetuses". Seminars in Perinatology. 28 (1): 59–66. doi:10.1053/j.semperi.2003.10.013. PMID 15058903.
  42. ^ "Safe Prevention of the Primary Cesarean Delivery". www.acog.org . Retrieved 2020-08-04 .
  43. ^ Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L (July 2013). "Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-assay for the U.S. Preventive Services Task Force and the National Institutes of Wellness Office of Medical Applications of Research". Annals of Internal Medicine. 159 (2): 123–9. doi:10.7326/0003-4819-159-two-201307160-00661. PMID 23712381. S2CID 21881403.
  44. ^ Guo L, Ma J, Tang J, Hu D, Zhang Westward, Zhao 10 (2019). "Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Assay". Journal of Diabetes Research. 2019: 9804708. doi:10.1155/2019/9804708. PMC6875019. PMID 31781670.
  45. ^ Butalia S, Gutierrez L, Lodha A, Aitken E, Zakariasen A, Donovan L (January 2017). "Short- and long-term outcomes of metformin compared with insulin solitary in pregnancy: a systematic review and meta-analysis". Diabetic Medicine. 34 (1): 27–36. doi:10.1111/dme.13150. PMID 27150509. S2CID 3418227.
  46. ^ a b Earth Health Organization (2016). WHO recommendations on antenatal care for a positive pregnancy feel. Geneva, Switzerland. ISBN978-92-4-154991-2. OCLC 974355266.
  47. ^ a b "Weight Gain During Pregnancy | Pregnancy | Maternal and Infant Health C". www.cdc.gov. 2019-01-17. Retrieved 2020-08-04 .
  48. ^ Santos S, Voerman E, Amiano P, Barros H, Beilin LJ, Bergström A, et al. (July 2019). "Impact of maternal trunk mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts". BJOG. 126 (8): 984–995. doi:10.1111/1471-0528.15661. PMC6554069. PMID 30786138.
  49. ^ a b Goldstein RF, Abell SK, Ranasinha S, Misso ML, Boyle JA, Harrison CL, et al. (August 2018). "Gestational weight proceeds across continents and ethnicity: systematic review and meta-analysis of maternal and babe outcomes in more than one million women". BMC Medicine. 16 (ane): 153. doi:10.1186/s12916-018-1128-1. PMC6117916. PMID 30165842.
  50. ^ Culliney KA, Parry GK, Dark-brown J, Crowther CA, et al. (Cochrane Pregnancy and Childbirth Group) (Apr 2016). "Regimens of fetal surveillance of suspected large-for-gestational-age fetuses for improving wellness outcomes". The Cochrane Database of Systematic Reviews. four: CD011739. doi:x.1002/14651858.CD011739.pub2. PMC7081118. PMID 27045604.
  51. ^ Miller V, Saxena Due south, Farhan M (2010). "Management of big-for-gestational-age pregnancy in non-diabetic women". The Obstetrician & Gynaecologist. 12 (4): 250–256. doi:10.1576/toag.12.iv.250.27617.

External links [edit]

dysonsorge1982.blogspot.com

Source: https://en.wikipedia.org/wiki/Large_for_gestational_age

Post a Comment for "Risks of Having a Baby Over 4000 Grams"